These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 23759297
1. Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients. Javaugue V, Karras A, Glowacki F, McGregor B, Lacombe C, Goujon JM, Ragot S, Aucouturier P, Touchard G, Bridoux F. Am J Kidney Dis; 2013 Oct; 62(4):679-90. PubMed ID: 23759297 [Abstract] [Full Text] [Related]
2. Membranous nephropathy with crescents: a series of 19 cases. Rodriguez EF, Nasr SH, Larsen CP, Sethi S, Fidler ME, Cornell LD. Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471 [Abstract] [Full Text] [Related]
3. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM. Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672 [Abstract] [Full Text] [Related]
4. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Bridoux F, Hugue V, Coldefy O, Goujon JM, Bauwens M, Sechet A, Preud'Homme JL, Touchard G. Kidney Int; 2002 Nov; 62(5):1764-75. PubMed ID: 12371978 [Abstract] [Full Text] [Related]
5. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab. Guiard E, Karras A, Plaisier E, Duong Van Huyen JP, Fakhouri F, Rougier JP, Noel LH, Callard P, Delahousse M, Ronco P. Clin J Am Soc Nephrol; 2011 Jul; 6(7):1609-16. PubMed ID: 21700823 [Abstract] [Full Text] [Related]
6. Fibrillary Glomerulonephritis: Clinicopathologic Features and Atypical Cases from a Multi-Institutional Cohort. Andeen NK, Troxell ML, Riazy M, Avasare RS, Lapasia J, Jefferson JA, Akilesh S, Najafian B, Nicosia RF, Alpers CE, Smith KD. Clin J Am Soc Nephrol; 2019 Dec 06; 14(12):1741-1750. PubMed ID: 31685544 [Abstract] [Full Text] [Related]
7. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features. Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D'Agati VD. Kidney Int; 2003 Apr 06; 63(4):1450-61. PubMed ID: 12631361 [Abstract] [Full Text] [Related]
8. Rituximab treatment of fibrillary glomerulonephritis. Collins M, Navaneethan SD, Chung M, Sloand J, Goldman B, Appel G, Rovin BH. Am J Kidney Dis; 2008 Dec 06; 52(6):1158-62. PubMed ID: 18823685 [Abstract] [Full Text] [Related]
9. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients. Chauvet S, Bridoux F, Ecotière L, Javaugue V, Sirac C, Arnulf B, Thierry A, Quellard N, Milin S, Bender S, Goujon JM, Jaccard A, Fermand JP, Touchard G. Am J Kidney Dis; 2015 Nov 06; 66(5):756-67. PubMed ID: 25987261 [Abstract] [Full Text] [Related]
10. [Prognosis and treatment of membranous glomerulonephritis-a 5-year prospective study]. Covic A, Căruntu ID, Marian D, Volovăţ C, Ghiciuc C, Costin C, Florea L, Cotuţiu C, Covic M. Rev Med Chir Soc Med Nat Iasi; 2000 Nov 06; 104(2):63-74. PubMed ID: 12089993 [Abstract] [Full Text] [Related]
11. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients. Khalighi MA, Wang S, Henriksen KJ, Bock M, Keswani M, Chang A, Meehan SM. Pediatr Nephrol; 2015 Jun 06; 30(6):953-9. PubMed ID: 25669759 [Abstract] [Full Text] [Related]
13. Primary glomerulonephritis: an update on renal survival and determinants of progression. Moranne O, Watier L, Rossert J, Stengel B, GN-Progress Study Group. QJM; 2008 Mar 06; 101(3):215-24. PubMed ID: 18245806 [Abstract] [Full Text] [Related]
14. Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Nasr SH, Valeri AM, Appel GB, Sherwinter J, Stokes MB, Said SM, Markowitz GS, D'Agati VD. Clin J Am Soc Nephrol; 2009 Jan 06; 4(1):22-32. PubMed ID: 18971369 [Abstract] [Full Text] [Related]
15. Clinicopathological study of mixed cryoglobulinemic glomerulonephritis secondary to hepatitis B virus infection. Li C, Li H, Su W, Wen YB, Ye W, Ye WL, Cai JF, Qin XZ, Li XM, Li XW. BMC Nephrol; 2020 Sep 14; 21(1):395. PubMed ID: 32928133 [Abstract] [Full Text] [Related]
16. Congophilic Fibrillary Glomerulonephritis: A Case Series. Alexander MP, Dasari S, Vrana JA, Riopel J, Valeri AM, Markowitz GS, Hever A, Bijol V, Larsen CP, Cornell LD, Fidler ME, Said SM, Sethi S, Herrera Hernandez LP, Grande JP, Erickson SB, Fervenza FC, Leung N, Kurtin PJ, Nasr SH. Am J Kidney Dis; 2018 Sep 14; 72(3):325-336. PubMed ID: 29866458 [Abstract] [Full Text] [Related]
17. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions. Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E. Clin Nephrol; 1996 Oct 14; 46(4):237-44. PubMed ID: 8905208 [Abstract] [Full Text] [Related]
18. [Glomerulonephritis and vasculitis as causes of arterial hypertension]. Eicken S, Gugger M, Marti HP. Ther Umsch; 2012 May 14; 69(5):283-94. PubMed ID: 22547360 [Abstract] [Full Text] [Related]
19. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis. Ott U, Aschoff A, Pocock J, Fünfstück R, Jirikowski G, Stein G, Wolf G. Nephron Clin Pract; 2007 May 14; 105(1):c18-28. PubMed ID: 17114899 [Abstract] [Full Text] [Related]
20. [Treatment of post-transplant glomerulonephritis]. Sandrini S, Valerio F. G Ital Nefrol; 2008 May 14; 25 Suppl 44():99-106. PubMed ID: 19048593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]